158 related articles for article (PubMed ID: 7510519)
1. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor.
Huang RR; Yu H; Strader CD; Fong TM
Biochemistry; 1994 Mar; 33(10):3007-13. PubMed ID: 7510519
[TBL] [Abstract][Full Text] [Related]
2. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding.
Rosenkilde MM; Cahir M; Gether U; Hjorth SA; Schwartz TW
J Biol Chem; 1994 Nov; 269(45):28160-4. PubMed ID: 7525569
[TBL] [Abstract][Full Text] [Related]
3. Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P.
Zoffmann S; Gether U; Schwartz TW
FEBS Lett; 1993 Dec; 336(3):506-10. PubMed ID: 7506676
[TBL] [Abstract][Full Text] [Related]
4. Conformational compatibility as a basis of differential affinities of tachykinins for the neurokinin-1 receptor.
Huang RR; Huang D; Strader CD; Fong TM
Biochemistry; 1995 Dec; 34(50):16467-72. PubMed ID: 8845375
[TBL] [Abstract][Full Text] [Related]
5. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.
Fong TM; Huang RR; Strader CD
J Biol Chem; 1992 Dec; 267(36):25664-7. PubMed ID: 1281469
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues involved in ligand binding to the neurokinin-2 receptor.
Huang RR; Vicario PP; Strader CD; Fong TM
Biochemistry; 1995 Aug; 34(31):10048-55. PubMed ID: 7543277
[TBL] [Abstract][Full Text] [Related]
7. Identification in the NK1 tachykinin receptor of a domain involved in recognition of neurokinin A and septide but not of substance P.
Wijkhuisen A; Sagot MA; Frobert Y; Créminon C; Grassi J; Boquet D; Couraud JY
FEBS Lett; 1999 Mar; 447(2-3):155-9. PubMed ID: 10214937
[TBL] [Abstract][Full Text] [Related]
8. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor.
Girault S; Sagan S; Bolbach G; Lavielle S; Chassaing G
Eur J Biochem; 1996 Aug; 240(1):215-22. PubMed ID: 8797856
[TBL] [Abstract][Full Text] [Related]
9. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD
J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807
[TBL] [Abstract][Full Text] [Related]
11. Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists.
Fong TM; Yu H; Cascieri MA; Underwood D; Swain CJ; Strader CD
J Biol Chem; 1994 May; 269(21):14957-61. PubMed ID: 8195129
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex.
Macdonald D; Mierke DF; Li H; Pellegrini M; Sachais B; Krause JE; Leeman SE; Boyd ND
Biochemistry; 2001 Feb; 40(8):2530-9. PubMed ID: 11327875
[TBL] [Abstract][Full Text] [Related]
13. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides.
Fong TM; Yu H; Huang RR; Strader CD
Biochemistry; 1992 Dec; 31(47):11806-11. PubMed ID: 1280161
[TBL] [Abstract][Full Text] [Related]
14. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.
Huang RR; Yu H; Strader CD; Fong TM
Mol Pharmacol; 1994 Apr; 45(4):690-5. PubMed ID: 8183248
[TBL] [Abstract][Full Text] [Related]
15. Structural motifs encoded by individual exons of the human neurokinin-1 receptor gene interact differentially with selective agonists and antagonists.
Tian Y; Wu LH; Pu Y; Huang CC; Chung FZ
J Neurochem; 1996 Sep; 67(3):1191-9. PubMed ID: 8752126
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of neurokinin receptor function.
Fong TM; Huang RC; Yu H; Swain CJ; Underwood D; Cascieri MA; Strader CD
Can J Physiol Pharmacol; 1995 Jul; 73(7):860-5. PubMed ID: 8846422
[TBL] [Abstract][Full Text] [Related]
17. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
Brodbeck RM; Sachais BS; Krause JE
Mol Pharmacol; 1995 May; 47(5):1065-71. PubMed ID: 7538194
[TBL] [Abstract][Full Text] [Related]
18. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
Pradier L; Ménager J; Le Guern J; Bock MD; Heuillet E; Fardin V; Garret C; Doble A; Mayaux JF
Mol Pharmacol; 1994 Feb; 45(2):287-93. PubMed ID: 7509440
[TBL] [Abstract][Full Text] [Related]
19. The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ.
Greenfeder S; Cheewatrakoolpong B; Billah M; Egan RW; Keene E; Murgolo NJ; Anthes JC
Bioorg Med Chem; 1999 Dec; 7(12):2867-76. PubMed ID: 10658591
[TBL] [Abstract][Full Text] [Related]
20. Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septide.
Fardin V; Foucault F; Bock MD; Jolly A; Flamand O; Clerc F; Garret C
Regul Pept; 1993 Jul; 46(1-2):300-3. PubMed ID: 7692521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
